The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription
- 30 April 2017
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (9) , 2522-2533
Abstract
Myc oncoproteins exert tumorigenic effects by regulating expression of target oncogenes. Histone H3 lysine 79 (H3K79) methylation at Myc-responsive elements of target gene promoters is a strict prerequisite for Myc-induced transcriptional activation, and DOT1L is the only known histone methyltransferase that catalyzes H3K79 methylation. Here, we show that N-Myc upregulates DOT1L mRNA and protein expression by binding to the DOT1L gene promoter. shRNA-mediated depletion of DOT1L reduced mRNA and protein expression of N-Myc target genes ODC1 and E2F2. DOT1L bound to the Myc Box II domain of N-Myc protein, and knockdown of DOT1L reduced histone H3K79 methylation and N-Myc protein binding at the ODC1 and E2F2 gene promoters and reduced neuroblastoma cell proliferation. Treatment with the small-molecule DOT1L inhibitor SGC0946 reduced H3K79 methylation and proliferation of MYCN gene–amplified neuroblastoma cells. In mice xenografts of neuroblastoma cells stably expressing doxycycline-inducible DOT1L shRNA, ablating DOT1L expression with doxycycline significantly reduced ODC1 and E2F2 expression, reduced tumor progression, and improved overall survival. In addition, high levels of DOT1L gene expression in human neuroblastoma tissues correlated with high levels of MYCN, ODC1, and E2F2 gene expression and independently correlated with poor patient survival. Taken together, our results identify DOT1L as a novel cofactor in N-Myc–mediated transcriptional activation of target genes and neuroblastoma oncogenesis. Furthermore, they characterize DOT1L inhibitors as novel anticancer agents against MYCN-amplified neuroblastoma. Cancer Res; 77(9); 2522–33. ©2017 AACR.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastomaCell Death & Disease, 2013
- Chromatin-modifying enzymes as modulators of reprogrammingNature, 2012
- The diverse functions of Dot1 and H3K79 methylationGenes & Development, 2011
- DOT1L, the H3K79 methyltransferase, is required for MLL-AF9–mediated leukemogenesisBlood, 2011
- Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patientsThe Pharmacogenomics Journal, 2010
- Recent Advances in NeuroblastomaNew England Journal of Medicine, 2010
- ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in NeuroblastomaCancer Research, 2008
- Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic ratsProceedings of the National Academy of Sciences, 2008
- Myc’s broad reachGenes & Development, 2008
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007